Medicine Information

Neurontin Lawsuit: Neurontin Off-Label Abuse Lawyer


Pfizer is currently marketing Neurontin as an oral medication for managing postherptic neuralgia, the pain that lingers after shingles has healed. This is an FDA-approved use, and studies have shown that Neurontin works to reduce patients' pain. It is a good drug, with many useful applications and few negative side effects, but it has a surprisingly long and sordid past.

Neurontin was originally approved in 1993 for the treatment of partial seizures in adults and children, especially epileptic seizures. However, this limited market for a drug with so few side effects was not enough for the company, Warner-Lambert. The company set up a massive campaign to improve sales of Neurontin, and it worked. By 2002 Neurontin was a $2 billion dollar drug, outselling even Viagra. How did a little epilepsy drug come to claim such a huge number of patients? It did so illicitly.

There are not enough patients suffering from epilepsy that one drug could earn profits of $2 billion a year. In order to claim these kinds of profits, Warner-Lambert began promoting the drug for off-label uses. The company sent representatives directly to doctors, urging them to prescribe Neurontin for to treat not only epilepsy but also bipolar disorder, alcohol withdrawal, cocaine abuse, HIV/AIDS neuropathy, phantom limb pain, anxiety, and a host of other diverse and unrelated conditions.

Though it has since been shown to work for some of these conditions, it was not clear at the time exactly what Neurontin did. The Warner-Lambert salesmen were lying to doctors about what Neurontin could do, and the doctors were listening. While it is illegal for a drug company to promote off-label uses directly and immoral to bribe doctors into prescribing a certain drug, it was also absolutely dangerous to claim Neurontin could cure disorders that it simply couldn't.

For example, Neurontin has no effect on bipolar disorder. Warner-Lambert sold thousands of doctors on the idea that Neurontin should be prescribed for bipolar disorder. If it did not work, they suggested increasing the dosage. One of the drug company managers told a salesman: "I don't want to see a single patient coming off Neurontin before they've been up to at least 4,800 milligrams a day. I don't want to hear that safety crap either.... It's a great drug." An untold number of bipolar patients were taken off their FDA-approved medication and prescribed Neurontin alone. Although Neurontin has few side effects, it also did nothing for their disorder, leaving these patients effectively unmedicated. Nobody knows how many lives were shattered as a result, but unmedicated bipolar disorder has a mortality rate of 55-60%.

Luckily for the public and patients taking Neurontin, a Warner-Lambert sales representative came forward and revealed the entire scandal. Pfizer has now purchased the Warner-Lambert Company, making Pfizer responsible for the injuries caused by the drug it now profits from. Lawsuits are being filed to claim damages for the dangerous corporate marketing strategies that have caused so much pain. If you or someone you love was wrongly administered Neurontin, please contact a lawyer and discuss your options.

To find out why you need a Neurontin lawyer and read articles about dangerous drugs and Neurontin side effects, visit our website at hugesettlements.com.

If you have any questions or concerns about filing a Neurontin lawsuit, please contact a professional Neurontin attorney right away!


MORE RESOURCES:

National Academy of Sports Medicine Launches New Course ...
MarketWatch - 9 hours ago
CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ...


PR Web (press release)

BodyLogicMD Sponsors American Academy of Anti-Aging Medicine
MarketWatch - 17 hours ago
"It is a natural step for BodyLogicMD in terms of demonstrating our growth and support in the field of anti-aging medicine and bioidentical hormone therapy. ...
BodyLogicMD Opens Bioidentical Hormone Therapy Location in Chicago PR Web (press release)
all 12 news articles


University of South Alabama College of Medicine Chooses MDaudit(TM)
MarketWatch - 3 hours ago
... WIRE) -- Hayes Management Consulting announced today that it will provide its MDaudit(TM) software to University of South Alabama College of Medicine. ...


WNCT

Three Employees Fired After Patient Chokes on Medicine, Dies
FOXNews - Nov 20, 2008
GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ...
Firings a good first step in neglect case CharlotteObserver.com
all 38 news articles


BBC News

The uneasy link between war and medicine
BBC News, UK - 13 hours ago
Each portray the stark realities of war in their time, and show how medicine has struggled over the years to heal the injured. In one corner of the Wellcome ...
War and Medicine at the Wellcome Collection, NW1 Times Online
all 2 news articles


guardian.co.uk

The wrong medicine
TheDay, CT - 11 hours ago
If we had any reasonable expectation that a $25 billion federal loan would fix what ails the Detroit auto industry, we would support it. ...
Auto bailout must come with strings Visalia Times-Delta
all 1,404 news articles


Entry Level Finding Ways to Help Children With Cancer
New York Times, United States - 5 hours ago
She comes to the job with a master’s degree in Oriental medicine from Touro College and a lifelong love of cooking. On doing acupuncture on small children: ...


Tongjitang Chinese Medicines Company to Announce Third Quarter ...
FOXBusiness - 5 hours ago
Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, ...


Overworked doctors would not recommend careers in medicine
SmartBrief, DC - 3 hours ago
A survey of primary care doctors indicates most feel overworked and would not recommend medicine as a career. Nearly half the doctors who responded to the ...


Research and Markets: This Global Research Report in Medicine and ...
MarketWatch - Nov 19, 2008
Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D. ...

Medicine - Google News

home | site map
© 2006